TTrialPathMatch Me to Trials
← Back to trials
RecruitingDysphoniaPrimary Muscle Tension Dysphonia (MTD)

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes

Eligible age

16–65 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are: * To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes. * To determine the association between overall dysphonia outcomes and adoption of clear speech.

Sponsor: Emory University

You may qualify if…

  • Non-smoking
  • Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
  • No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
  • No history of voice therapy or voice surgery in the last year
  • No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist,
  • Willingness to attend all therapeutic interventions and follow-up sessions
  • Willingness to use a smartphone to record practice

You may not qualify if…

  • History of voice therapy or voice surgery in the last year
  • Serious chronic medical condition that may affect voice (per patient report)
  • Abnormal hearing ability (despite appropriate amplification)
  • Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
  • Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
  • Unwillingness to attend therapeutic intervention and follow-up sessions
  • Unwillingness to use a smartphone to record practice
  • Pregnant women

Where it's recruiting

Georgia

Atlanta

Source: ClinicalTrials.gov · NCT07176988 · last updated 2025-10-20

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes · TrialPath